NCT02815748View on ClinicalTrials.gov

The Metabolite Identification and Material Balance Study of SP2086

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

SP2086

SP2086 was taken only one time at 100mg dose in health volunteers

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02815748 - The Metabolite Identification and Material Balance Study of SP2086 | Biotech Hunter | Biotech Hunter